Hearing loss in osteogenesis imperfecta: characteristics and treatment considerations

Joseph P Pillion, David Vernick, Jay Shapiro, Joseph P Pillion, David Vernick, Jay Shapiro

Abstract

Osteogenesis imperfecta (OI) is the most common heritable disorder of connective tissue. It is associated with fractures following relatively minor injury, blue sclerae, dentinogenesis imperfecta, increased joint mobility, short stature, and hearing loss. Structures in the otic capsule and inner ear share in the histologic features common to other skeletal tissues. OI is due to mutations involving several genes, the most commonly involved are the COL1A1 or COL1A2 genes which are responsible for the synthesis of the proalpha-1 and proalpha-2 polypeptide chains that form the type I collagen triple helix. A genotype/phenotype relationship to hearing loss has not been established in OI. Hearing loss is commonly found in OI with prevalence rates ranging from 50 to 92% in some studies. Hearing loss in OI may be conductive, mixed, or sensorineural and is more common by the second or third decade. Treatment options such as hearing aids, stapes surgery, and cochlear implants are discussed.

References

    1. McKusick VA. Heritable disorders of connective tissue. V. Osteogenesis imperfecta. Journal of Chronic Diseases. 1956;3(2):180–202.
    1. Marini JC, Cabral WA, Barnes AM. Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta. Cell and Tissue Research. 2010;339(1):59–70.
    1. Becker J, Semler O, Gilissen C, et al. Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. American Journal of Human Genetics. 2011;88(3):362–371.
    1. Baldridge D, Schwarze U, Morello R, et al. CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta. Human Mutation. 2008;29(12):1435–1442.
    1. Homan EP, Rauch F, Grafe I, et al. Mutations in SERPINF1 cause osteogenesis imperfecta type VI. Journal of Bone and Mineral Research. 2011;26(12):2798–2803.
    1. Christiansen HE, Schwarze U, Pyott SM, et al. Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. American Journal of Human Genetics. 2010;86(3):389–398.
    1. Pyott SM, Schwarze U, Christiansen HE, et al. Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes. Human Molecular Genetics. 2011;20(8):1595–1609.
    1. van Dijk FS, Nikkels PG, den Hollander NS, et al. Lethal/severe osteogenesis imperfecta in a large family: a novel homozygous LEPRE1 mutation and bone histological findings. Pediatric and Developmental Pathology. 2011;14(3):228–234.
    1. Hartikka H, Kuurila K, Körkkö J, et al. Lack of correlation between the type of COL1A1 or COL1A2 mutation and hearing loss in osteogenesis imperfecta patients. Human Mutation. 2004;24(2):147–154.
    1. Lanting PJH, Borsboom PCF, te Meerman GJ, Kate LPT. Decreased scattering coefficient of blue sclerae. Clinical Genetics. 1985;27(2):187–190.
    1. Berger G, Hawke M, Johnson A, Proops D. Histopathology of the temporal bone in osteogenesis imperfecta congenita: a report of 5 cases. Laryngoscope. 1985;95(2):193–199.
    1. Zajtchuk JT, Lindsay JR. Osteogenesis imperfecta congenita and tarda: a temporal bone report. Annals of Otology, Rhinology and Laryngology. 1975;84(3, part 1):350–358.
    1. Valdezate LAV, Martín Gil J, José-Yacamán M, Gil FJM, Gil-Carcedo LM, Laso JLH. Otosclerosis and van der Hoeven’s syndrome: a contribution. Acta Otorrinolaringologica Espanola. 2001;52(2):85–93.
    1. Alkadhi H, Rissmann D, Kollias SS. Osteogenesis imperfecta of the temporal bone: CT and MR imaging in Van der Hoeve-de Kleyn syndrome. American Journal of Neuroradiology. 2004;25(6):1106–1109.
    1. Ziyeh S, Berger R, Reisner K. MRI-visible pericochlear lesions in osteogenesis imperfecta type I. European Radiology. 2000;10(10):1675–1677.
    1. Stewart EJ, O’Reilly BF. A clinical and audiological investigation of osteogenesis imperfecta. Clinical Otolaryngology and Allied Sciences. 1989;14(6):509–514.
    1. Kuurila K, Kaitila I, Johansson R, Grénman R. Hearing loss in finnish adults with osteogenesis imperfecta: a nationwide survey. Annals of Otology, Rhinology and Laryngology. 2002;111(10):939–946.
    1. Pillion JP, Shapiro J. Audiological findings in osteogenesis imperfecta. Journal of the American Academy of Audiology. 2008;19(8):595–601.
    1. Riedner ED, Leven LS, Holliday MJ. Hearing patterns in dominant osteogenesis imperfecta. Archives of Otolaryngology. 1980;106(12):737–740.
    1. Cox JR, Simmons CL. Osteogenesis imperfecta and associated hearing loss in five kindreds. Southern Medical Journal. 1982;75(10):1222–1226.
    1. Pedersen U. Hearing loss in patients with osteogenesis imperfecta. A clinical and audiological study of 201 patients. Scandinavian Audiology. 1984;13(2):67–74.
    1. Imani P, Vijayasekaran S, Lannigan FJ. Is it necessary to screen for hearing loss in the paediatric population with osteogenesis imperfecta? Clinical Otolaryngology and Allied Sciences. 2003;28(3):199–202.
    1. Garretsen AJTM, Cremers CWRJ, Huygen PLM. Hearing loss (in nonoperated ears) in relation to age in osteogenesis imperfecta type I. Annals of Otology, Rhinology and Laryngology. 1997;106(7, part 1):575–582.
    1. Sillence D. Osteogenesis imperfecta: an expanding panorama of variants. Clinical Orthopaedics and Related Research. 1981;159:11–25.
    1. Swinnen FKR, De Leenheer EMR, Coucke PJ, Cremers CWRJ, Dhooge IJM. Audiometric, surgical, and genetic findings in 15 ears of patients with osteogenesis imperfecta. Laryngoscope. 2009;119(6):1171–1179.
    1. Sykes B, Ogilvie D, Wordsworth P, et al. Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2. American Journal of Human Genetics. 1990;46(2):293–307.
    1. Charnas LR, Marini JC. Communicating hydrocephalus, basilar invagination, and other neurologic features in osteogenesis imperfecta. Neurology. 1993;43(12):2603–2608.
    1. Quisling RW, Moore GR, Jahrsdoerfer RA, Cantrell RW. Osteogenesis imperfecta. A study of 160 family members. Archives of Otolaryngology. 1979;105(4):207–211.
    1. Shapiro JR, Pikus A, Weiss G, Rowe DW. Hearing and middle ear function in osteogenesis imperfecta. Journal of the American Medical Association. 1982;247(15):2120–2126.
    1. Albahnasawy L, Kishore A, O’Reilly BF. Results of stapes surgery on patients with osteogenesis imperfecta. Clinical Otolaryngology and Allied Sciences. 2001;26(6):473–476.
    1. Bergstrom L. Fragile bones and fragile ears. Clinical Orthopaedics and Related Research. 1981;159:58–63.
    1. Pedersen U, Melsen F, Elbrond O, Charles P. Histopathology of the stapes in osteogenesis imperfecta. Journal of Laryngology and Otology. 1985;99(5):451–458.
    1. Heimert TL, Lin DDM, Yousem DM. Case 48: osteogenesis imperfecta of the temporal bone. Radiology. 2002;224(1):166–170.
    1. Holdsworth CE, Endahl GL, Soifer N, Richardson KE, Eyring EJ. Comparative biochemical study of otosclerosis and osteogenesis imperfecta. Archives of Otolaryngology. 1973;98(5):336–339.
    1. Kuurila K, Grénman R, Johansson R, Kaitila I. Hearing loss in children with osteogenesis imperfecta. European Journal of Pediatrics. 2000;159(7):515–519.
    1. Kuurila K, Grenman R. Response to “Is it necessary to screen for hearing loss in the pediatric population with osteogenesis imperfecta?”. Clinical Otolaryngology & Allied Sciences. 2004;29(3):p. 287.
    1. Taylor CL, Brooks RP. Screening for hearing loss and middle-ear disorders in children using TEOAEs. American Journal of Audiology. 2000;9(1):50–55.
    1. Driscoll C, Kei J, McPherson B. Outcomes of transient evoked otoacoustic emission testing in 6-year-old school children: a comparison with pure tone screening and tympanometry. International Journal of Pediatric Otorhinolaryngology. 2001;57(1):67–76.
    1. Shohat M, Flaum E, Cobb SR, et al. Hearing loss and temporal bone structure in achondroplasia. American Journal of Medical Genetics. 1993;45(5):548–551.
    1. Hall JW, III, Bratt GW, Schwaber MK, Baer JE. Dynamic sensorineural hearing loss: implications for audiologists: case reports. Journal of the American Academy of Audiology. 1993;4(6):399–411.
    1. Humes LE. The middle ear inertial component of bone-conduction hearing in man. Audiology. 1979;18(1):24–35.
    1. Feldman AS. Eardrum abnormality and the measurement of middle ear function. Archives of Otolaryngology. 1974;99(3):211–217.
    1. Rawool VW, Harrington BT. Middle ear admittance and hearing abnormalities in individuals with osteoarthritis. Audiology and Neurotology. 2007;12(2):127–136.
    1. De Ceulaer G, Somers T, Offeciers FE, Govaerts PJ. Middle ear status in ears showing high admittance tympanograms. Clinical value of the use of the two-component 678 Hz oto-admittance tympanogram. Acta Oto-Rhino-Laryngologica Belgica. 2002;56(3):313–317.
    1. Rotteveel LJC, Beynon AJ, Mens LHM, Snik AFM, Mulder JJ, Mylanus EAM. Cochlear implantation in 3 patients with osteogenesis imperfecta: imaging, surgery and programming issues. Audiology and Neurotology. 2008;13(2):73–85.
    1. Streubel SO, Lustig LR. Cochlear implantation in patients with osteogenesis imperfecta. Otolaryngology—Head and Neck Surgery. 2005;132(5):735–740.
    1. Szilvássy J, Jóri J, Czigner J, Tóth F, Szilvássy Z, Kiss JG. Cochlear implantation in osteogenesis imperfecta. Acta Oto-Rhino-Laryngologica Belgica. 1998;52(3):253–256.
    1. Kontorinis G, Lenarz T, Mojallal H, Hinze AL, Schwab B. Power stapes: an alternative method for treating hearing loss in osteogenesis imperfecta? Otology and Neurotology. 2011;32(4):589–595.
    1. Garretsen TJ, Cremers CW. Stapes surgery in osteogenesis imperfecta: analysis of postoperative hearing loss. Ann Otol Rhinol Laryngol. 1991;100(2):120–130.
    1. Shea JJ, Postma DS. Findings and long-term surgical results in the hearing loss of osteogenesis imperfecta. Arch Otolaryngol. 1982;108(8):467–470.
    1. Ferekidis E, Stavroulaki P, Vossinakis I, Yiotakis J, Manolopoulos L, Adamopoulos G. Stapedotomy in osteogenesis imperfecta patients. J Laryngol Otol. 2000;114(6):424–428.
    1. Vincent R, Gratacap B, Oates J, Sperling NM. Stapedotomy in osteogenesis imperfecta: a prospective study of 23 consecutive cases. Otol Neurotol. 2005;26(5):859–865.
    1. Vincent R, Sperling NM, Oates J, Jindal M. Surgical findings and long-term hearing results in 3,050 stapedotomies for primary otosclerosis: a prospective study with the otology-neurotology database. Otol Neurotol. 2006;27(8, supplement 2):S25–S47.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться